Edwards Lifesciences Corp at Goldman Sachs Global Healthcare Conference Transcript
Good morning, ladies and gentlemen, and thank you for joining us for another session here. My name is Veronika Dubajova, and I am a med tech analyst at Goldman Sachs. And it is with great pleasure this morning that I am joined by the management team from Edwards, Mike Mussallem, Chairman and CEO; and Scott Ullem, Chief Financial Officer. Gentlemen, thank you for being here. We really appreciate it.
This is meant to be an interactive session, so please raise your hands if you have a question. The session is webcast, so wait for mic before asking it. But I will kick us off and hopefully, we will have some questions from the audience as we go along.
Questions & Answers
Mike, I want to start with a high-level question. You've obviously been at the helm of Edwards for a very long time. And I --if I look at -- yes, this is our 40th conference, and one of the things we looked at was which
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |